BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27752292)

  • 1. Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Yang J; Ge H; Poulton CJ; Hogan SL; Hu Y; Jones BE; Henderson CD; McInnis EA; Pendergraft WF; Jennette JC; Falk RJ; Ciavatta DJ
    Clin Epigenetics; 2016; 8():85. PubMed ID: 27752292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis.
    Jones BE; Yang J; Muthigi A; Hogan SL; Hu Y; Starmer J; Henderson CD; Poulton CJ; Brant EJ; Pendergraft WF; Jennette JC; Falk RJ; Ciavatta DJ
    J Am Soc Nephrol; 2017 Apr; 28(4):1175-1187. PubMed ID: 27821628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activation.
    Jones BE; Herrera CA; Agosto-Burgos C; Starmer J; Bass WA; Poulton CJ; Blazek L; Henderson CD; Hu Y; Hogan SL; Hu P; Xiao H; Wu EY; Chen DP; Jennette JC; Free ME; Falk RJ; Ciavatta DJ
    Kidney Int; 2020 Sep; 98(3):744-757. PubMed ID: 32446935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis.
    Ciavatta DJ; Yang J; Preston GA; Badhwar AK; Xiao H; Hewins P; Nester CM; Pendergraft WF; Magnuson TR; Jennette JC; Falk RJ
    J Clin Invest; 2010 Sep; 120(9):3209-19. PubMed ID: 20714105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of autoantigen genes in ANCA-associated vasculitis involves alternative transcripts and new protein synthesis.
    McInnis EA; Badhwar AK; Muthigi A; Lardinois OM; Allred SC; Yang J; Free ME; Jennette JC; Preston GA; Falk RJ; Ciavatta DJ
    J Am Soc Nephrol; 2015 Feb; 26(2):390-9. PubMed ID: 25060059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease.
    Chen DP; Aiello CP; McCoy D; Stamey T; Yang J; Hogan SL; Hu Y; Derebail VK; Wu EY; Jennette JC; Falk RJ; Ciavatta DJ
    JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36626226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent pathogenetic advances in ANCA-associated vasculitis.
    Pendergraft WF; Nachman PH
    Presse Med; 2015 Jun; 44(6 Pt 2):e223-9. PubMed ID: 26033562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphism.
    Casal Moura M; Deng Z; Brooks SR; Tew W; Fervenza FC; Kallenberg CGM; Langford CA; Merkel PA; Monach PA; Seo P; Spiera RF; St Clair EW; Stone JH; Prunotto M; Grayson PC; Specks U
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36990659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
    Merkel PA; Xie G; Monach PA; Ji X; Ciavatta DJ; Byun J; Pinder BD; Zhao A; Zhang J; Tadesse Y; Qian D; Weirauch M; Nair R; Tsoi A; Pagnoux C; Carette S; Chung S; Cuthbertson D; Davis JC; Dellaripa PF; Forbess L; Gewurz-Singer O; Hoffman GS; Khalidi N; Koening C; Langford CA; Mahr AD; McAlear C; Moreland L; Seo EP; Specks U; Spiera RF; Sreih A; St Clair EW; Stone JH; Ytterberg SR; Elder JT; Qu J; Ochi T; Hirano N; Edberg JC; Falk RJ; Amos CI; Siminovitch KA;
    Arthritis Rheumatol; 2017 May; 69(5):1054-1066. PubMed ID: 28029757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective α1-antitrypsin effects in autoimmune vasculitis are compromised by methionine oxidation.
    Ebert M; Jerke U; Eulenberg-Gustavus C; Kling L; Jenne D; Kirchner M; Mertins P; Bieringer M; Elitok S; Eckardt KU; Schreiber A; Salama AD; Kettritz R
    J Clin Invest; 2022 Dec; 132(23):. PubMed ID: 36125911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.
    Hilhorst M; van Paassen P; Tervaert JW;
    J Am Soc Nephrol; 2015 Oct; 26(10):2314-27. PubMed ID: 25956510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD14 expression is increased on monocytes in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis and correlates with the expression of ANCA autoantigens.
    Tarzi RM; Liu J; Schneiter S; Hill NR; Page TH; Cook HT; Pusey CD; Woollard KJ
    Clin Exp Immunol; 2015 Jul; 181(1):65-75. PubMed ID: 25766482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Harper L; Cockwell P; Adu D; Savage CO
    Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis.
    Ekman D; Sennblad B; Knight A; Karlsson Å; Rantapää-Dahlqvist S; Berglin E; Stegmayr B; Baslund B; Palm Ø; Haukeland H; Gunnarsson I; Bruchfeld A; Segelmark M; Ohlsson S; Mohammad AJ; Svärd A; Pullerits R; Herlitz H; Söderbergh A; Omdal R; Jonsson R; Rönnblom L; Eriksson P; Lindblad-Toh K; Dahlqvist J
    Rheumatology (Oxford); 2023 Sep; 62(9):3213-3218. PubMed ID: 37004177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).
    Manojlovic M; Juto A; Jonasdottir A; Colic J; Vojinovic J; Nordin A; Bruchfeld A; Gunnarsson I; Mobarrez F; Antovic A
    J Mol Med (Berl); 2020 Sep; 98(9):1279-1286. PubMed ID: 32734361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Grayson PC; Carmona-Rivera C; Xu L; Lim N; Gao Z; Asare AL; Specks U; Stone JH; Seo P; Spiera RF; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Ytterberg SR; Phippard DJ; Merkel PA; Kaplan MJ; Monach PA;
    Arthritis Rheumatol; 2015 Jul; 67(7):1922-32. PubMed ID: 25891759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Cathepsin C in PR3-ANCA Vasculitis.
    Jerke U; Eulenberg-Gustavus C; Rousselle A; Nicklin P; Kreideweiss S; Grundl MA; Eickholz P; Nickles K; Schreiber A; Korkmaz B; Kettritz R
    J Am Soc Nephrol; 2022 May; 33(5):936-947. PubMed ID: 35292437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
    Mohammad AJ; Segelmark M
    J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A myelopoiesis gene signature during remission in anti-neutrophil cytoplasm antibody-associated vasculitis does not predict relapses but seems to reflect ongoing prednisolone therapy.
    Kurz T; Weiner M; Skoglund C; Basnet S; Eriksson P; Segelmark M
    Clin Exp Immunol; 2014 Feb; 175(2):215-26. PubMed ID: 24215168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA-associated vasculitis.
    Holding S; Fisher VJ; Abuzakouk M
    Ann Clin Biochem; 2015 Mar; 52(Pt 2):297-301. PubMed ID: 24723621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.